pseudotumor cerebri: Idiopathic intracranial hypertension is a neurological disorder characterized by isolated increased intracranial pressure manifesting with recurrent and persistent headaches, nausea, vomiting, progressive and transient obstruction of the visual field, papilledema. Visual loss can be irreversible.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
462 |
4. Check minimum number of eventsNone |
462 |
5. Include endpointsNone |
462 |
6. Filter based on genotype QC (FinnGen only) |
404 |
Control definitions (FinnGen only)
- Control exclude
- G6_OTHNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G93
- Name in latin
- Hypertensio intracranialis benigna
Similar endpoints
↥List of similar endpoints to
Benign intracranial hypertension
based on the number of shared cases.
Similar with more cases:
- Other neurological diseases
- Neurological diseases
- Neurological diseases, wide definition
- Any operation in hilmo
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1710 | 1314 | 380 |
| Only index persons | 1612 | 1273 | 339 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.01 |
| Only index persons | 0.04 | 0.05 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 31.63 | 30.53 | 35.22 |
| Only index persons | 31.49 | 30.53 | 35.08 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 404 | 335 | 69 |
| Unadjusted period prevalence (%) | 0.10 | 0.12 | 0.03 |
| Median age at first event (years) | 34.71 | 33.35 | 41.31 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 422
- Matched controls
- 4220
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S01EC01
ATC
acetazolamide; systemic
619.5
307.7
311
19
G93.2
ICD-10 Finland
Benign intracranial hypertension
+∞
307.7
411
*
TAB00
NOMESCO Finland
Lumbar puncture
44.6
297.3
198
82
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
37.9
236.3
160
67
H47.1
ICD-10 Finland
Papilloedema, unspecified
448.7
225.1
207
9
Z01.0
ICD-10 Finland
Examination of eyes and vision
15.6
188.9
261
397
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
18.6
162.3
151
123
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
80.4
155.8
84
13
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
37.2
141.0
91
31
XCK00
NOMESCO Finland
Perimetry
23.3
140.2
110
63
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
13.1
130.2
152
174
CS494
NOMESCO Finland
Other visual field testing
36.7
106.2
68
22
R51.80
ICD-10 Finland
Headache
7.9
102.4
239
598
N03AX11
ATC
topiramate; oral
16.9
95.7
86
63
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
37.9
93.4
59
18
XCW99
NOMESCO Finland
Other investigative procedure of eye
9.9
85.0
114
152
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
16.8
75.8
67
47
AA1AD
NOMESCO Finland
CT of head and brain
5.8
64.0
158
392
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
29.8
63.5
43
16
E66.8
ICD-10 Finland
Other obesity
7.7
60.8
98
159
C03CA01
ATC
furosemide; systemic
6.7
60.7
116
225
E66.01
ICD-10 Finland
Obesity due to excess calories
5.8
60.6
145
348
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
614.5
55.9
54
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.6
55.3
106
205
H53.1
ICD-10 Finland
Subjective visual disturbances
6.9
48.4
84
146
XCK10
NOMESCO Finland
Photography of fundus of eye
5.8
33.7
68
135
E66.9
ICD-10 Finland
Obesity, unspecified
6.5
30.4
53
91
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.4
30.2
54
95
T82
ICPC
Obesity
5.9
28.3
55
105
G47.3
ICD-10 Finland
Sleep apnoea
3.6
27.0
110
375
G44.2
ICD-10 Finland
Tension-type headache
3.4
26.7
123
454
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.8
25.7
64
152
R4190
NOMESCO Finland
Nutritional therapy
5.6
24.7
50
99
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
5.5
23.1
48
97
XCH00
NOMESCO Finland
Eye pressure measurement
8.1
22.4
31
41
R42
ICD-10 Finland
Dizziness and giddiness
3.1
21.0
112
444
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.5
20.9
85
286
G43.3
ICD-10 Finland
Complicated migraine
6.8
20.9
34
54
C09CA06
ATC
candesartan; oral
2.9
20.0
117
487
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
19.9
19
*
N02AX02
ATC
tramadol; systemic, rectal
2.6
19.8
175
901
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
33.1
19.5
25
8
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
19.2
174
903
G43.9
ICD-10 Finland
Migraine, unspecified
3.3
19.0
82
286
H53.2
ICD-10 Finland
Diplopia
7.2
18.9
29
43
N03AX12
ATC
[U] gabapentin; oral
3.4
18.6
77
261
XCD10
NOMESCO Finland
Electrophysiological examination of eye
8.0
18.0
25
33
H02AB06
ATC
prednisolone; systemic
2.4
17.8
211
1229
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.9
17.2
98
399
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
16.8
16
*
E23.06
ICD-10 Finland
Empty sella
176.7
16.6
17
*
A02BC02
ATC
pantoprazole; systemic
2.4
16.4
279
1879
H47.3
ICD-10 Finland
Other disorders of optic disc
31.5
16.3
21
7
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
16.1
112
505
N02BF01
ATC
gabapentin; oral
3.6
16.0
57
175
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
165.9
15.6
16
*
I10
ICD-10 Finland
Essential (primary) hypertension
2.4
15.5
154
819
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
18.6
15.3
23
13
N03AX16
ATC
[U] pregabalin
2.7
15.0
93
394
PA2AD
NOMESCO Finland
CT angiography of brain
26.1
14.8
20
8
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
14.8
96
417
H47.2
ICD-10 Finland
Optic atrophy
83.1
14.7
16
*
G93.0
ICD-10 Finland
Cerebral cysts
155.2
14.6
15
*
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.4
14.4
126
629
3007
Kela drug reimbursment
Erenumab and fremanezumab
6.5
14.4
24
39
N06AX21
ATC
duloxetine; oral
2.9
14.3
77
302
G44.8
ICD-10 Finland
Other specified headache syndromes
6.8
13.8
22
34
AAF10
NOMESCO Finland
Lumboperitoneal shunt
+∞
13.6
13
*
H93.1
ICD-10 Finland
Tinnitus
3.9
13.4
41
113
A10BA02
ATC
metformin; oral
2.5
13.3
98
451
H02AB04
ATC
methylprednisolone; systemic
3.0
13.3
65
242
ZXA10
NOMESCO Finland
Bilateral
2.7
13.2
82
346
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
17.4
13.1
20
12
OAB72
NOMESCO Finland
Weight control and weight loss guidance
13.6
13.1
22
17
C08CA01
ATC
amlodipine; oral
2.5
13.1
95
434
E66
ICD-10 Finland
Obesity
3.3
12.9
51
167
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.3
12.6
51
169
SPAT1153
SPAT
Removal of sutures
2.3
12.6
118
603
H53.4
ICD-10 Finland
Visual field defects
13.7
12.6
21
16
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
12.6
12
*
3482A
ICD-9 Finland
Other conditions of brain, Benign intracranial hypertension
+∞
12.6
12
*
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
5.9
12.6
23
41
R03AC02
ATC
salbutamol; inhalant
2.2
12.5
276
1969
H02AB09
ATC
hydrocortisone; systemic
6.1
12.4
22
38
KH1AD
NOMESCO Finland
CT of urinary organs
5.4
12.4
25
49
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.6
12.3
80
345
DFF00
NOMESCO Finland
Pure tone audiometry
3.5
11.7
43
134
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
9.0
11.7
24
28
N20.1
ICD-10 Finland
Calculus of ureter
5.5
11.7
23
44
WX780
NOMESCO Finland
Remote monitoring CPAP
5.0
11.6
25
52
PH4YT
NOMESCO Finland
Dilatation of vein of head or brain
+∞
11.5
11
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
11.5
168
1020
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
11.4
102
509
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.9
11.3
56
209
J45.9
ICD-10 Finland
Asthma, unspecified
2.4
11.3
95
461
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
11.3
102
511
C07AB07
ATC
bisoprolol; oral
2.2
11.3
130
720
H53.9
ICD-10 Finland
Visual disturbance, unspecified
4.4
11.3
29
70
N06AX11
ATC
mirtazapine; oral
2.0
10.8
159
964
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.9
10.8
55
209
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.6
10.7
26
60
N05BA04
ATC
oxazepam; oral
2.1
10.6
123
681
A02BC05
ATC
esomeprazole; systemic
2.0
10.6
156
944
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.6
10.6
65
272
R51
ICD-10 Finland
Headache
2.9
10.5
53
200
G91.8
ICD-10 Finland
Other hydrocephalus
+∞
10.5
10
*
R01AD09
ATC
mometasone; nasal
2.0
10.4
237
1663
N06AX16
ATC
venlafaxine; oral
2.3
10.4
90
441
N05CF01
ATC
zopiclone; oral
2.2
10.4
115
624
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
4.2
10.2
28
71
B03BA03
ATC
hydroxocobalamin; parenteral
5.2
10.1
21
42
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
41.1
10.0
12
*
T83
ICPC
Overweight
4.7
9.9
23
51
M03BX02
ATC
tizanidine; oral
2.0
9.8
270
2004
SPAT1263
SPAT
Sampling
1.9
9.8
204
1380
N06AB04
ATC
citalopram; systemic
2.2
9.7
91
460
SPAT1255
SPAT
Intravenous administration of medicine
3.8
9.7
30
83
N01
ICPC
Headache
2.1
9.6
108
587
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
9.6
177
1148
N02BE01
ATC
paracetamol; systemic, rectal
2.7
9.6
377
3190
H57.1
ICD-10 Finland
Ocular pain
3.5
9.5
34
104
M01AE02
ATC
naproxen; oral, rectal
1.9
9.5
275
2067
R5140
NOMESCO Finland
Monitoring the use of the aid
3.1
9.5
40
136
AAF15
NOMESCO Finland
Ventriculoatrial shunt
+∞
9.4
9
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
+∞
9.4
9
*
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.4
9.3
69
316
C10AA05
ATC
atorvastatin; oral
2.2
9.2
86
434
SPAT1260
SPAT
Consultation of another employee
2.2
9.2
86
434
WX723
NOMESCO Finland
CPAP therapy
4.8
9.2
21
46
C09AA05
ATC
ramipril; oral
2.7
9.1
52
209
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
9.1
193
1305
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
8.9
96
512
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.6
8.9
21
47
A04AA01
ATC
ondansetron; systemic, rectal
3.1
8.9
38
130
SPAT1310
SPAT
Counselling related to known health issue
1.9
8.9
160
1025
J01FF01
ATC
clindamycin; systemic
2.0
8.9
116
666
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
8.9
47
182
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.8
8.8
45
171
N03AX09
ATC
lamotrigine; oral
2.9
8.6
43
161
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
16.7
8.6
13
8
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
8.6
197
1360
CS2P4
NOMESCO Finland
Optic nerve head imaging
28.2
8.5
11
*
205
Kela drug reimbursment
Chronic hypertension
2.8
8.5
43
162
WX725
NOMESCO Finland
Noninvasive ventilation
3.5
8.5
30
91
R33
ICD-10 Finland
Retention of urine
4.5
8.5
21
49
R03BA05
ATC
fluticasone; inhalant
2.1
8.5
98
537
C07AA05
ATC
propranolol; systemic
2.0
8.4
116
677
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.4
8.4
31
97
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
8.3
95
518
N05AH04
ATC
quetiapine; oral
2.0
8.3
109
626
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
3.6
8.2
27
78
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.5
8.2
56
246
T90
ICPC
Diabetes non-insulin dependent
2.3
8.2
65
306
N06AA09
ATC
amitriptyline; systemic
3.2
8.2
32
104
R53
ICD-10 Finland
Malaise and fatigue
1.9
8.1
134
829
WX720
NOMESCO Finland
Own respiration
3.6
8.1
27
79
SPAT1301
SPAT
No procedures
1.9
8.0
136
849
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.5
8.0
52
223
C09CA01
ATC
losartan; oral
2.3
8.0
64
302
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
7.9
62
290
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
9.7
7.8
15
16
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
7.8
189
1316
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
45.8
7.7
9
*
N02CC06
ATC
eletriptan; oral
3.1
7.7
33
113
J35.1
ICD-10 Finland
Hypertrophy of tonsils
3.6
7.7
25
72
M54.5
ICD-10 Finland
Low back pain
1.8
7.7
173
1177
E66.00
ICD-10 Finland
Metabolic syndrome
3.4
7.7
27
82
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.8
7.6
154
1013
G43.2
ICD-10 Finland
Status migrainosus
25.5
7.6
10
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
7.6
32
109
T07
ICPC
Weight gain
4.4
7.6
19
45
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.8
7.5
167
1128
WX110
NOMESCO Finland
Infiltration anesthesia
2.0
7.5
340
2839
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
7.5
47
198
XCW12
NOMESCO Finland
Assessment of colour vision
81.5
7.4
8
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
7.4
105
616
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
7.4
33
116
M03BC01
ATC
orphenadrine (citrate); systemic
1.9
7.4
105
617
SPAT1229
SPAT
Assessment of need for aid
4.3
7.3
19
46
R01AD08
ATC
fluticasone; nasal
1.8
7.3
141
912
G97.1
ICD-10 Finland
Other reaction to spinal and lumbar puncture
+∞
7.3
7
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.8
7.3
36
134
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.4
7.3
52
233
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
16.1
7.3
11
7
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.7
7.3
40
158
R50.9
ICD-10 Finland
Fever, unspecified
2.1
7.2
77
409
M79.6
ICD-10 Finland
Pain in limb
1.7
7.1
187
1321
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.4
7.1
51
229
L68.0
ICD-10 Finland
Hirsutism
9.0
7.1
14
16
R06.0
ICD-10 Finland
Dyspnoea
1.9
6.9
102
605
N05BA01
ATC
diazepam; systemic, rectal
2.4
6.9
49
219
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.2
6.9
61
300
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
3.2
6.9
27
88
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.3
6.8
17
28
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.3
6.8
26
83
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
17.0
6.8
10
6
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.7
6.8
252
1952
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
6.7
33
123
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.8
6.7
34
129
N89
ICPC
Migraine
2.4
6.7
46
203
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.3
6.6
50
230
SFA10
NOMESCO Finland
One-surface restoration
1.7
6.6
270
2140
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
6.6
56
271
SFA20
NOMESCO Finland
Two-surface restoration
1.7
6.5
277
2214
R06AE07
ATC
cetirizine; oral
1.7
6.5
209
1552
H03AA01
ATC
levothyroxine sodium; systemic
1.9
6.4
96
570
N02CD02
ATC
galcanezumab; parenteral
14.6
6.4
10
7
A10BJ02
ATC
liraglutide; parenteral
4.2
6.4
17
42
WX704
NOMESCO Finland
Intubation
2.6
6.4
38
156
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
6.3
54
261
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.3
6.3
47
214
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.2
6.3
59
296
XCW10
NOMESCO Finland
Assessment of vision
11.3
6.3
11
10
SPAT1312
SPAT
General health counselling
1.7
6.3
164
1146
EB1VA, ,
NOMESCO Finland
1.9
6.3
87
504
G93.1
ICD-10 Finland
Anoxic brain damage, not elsewhere classified
+∞
6.3
6
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
6.3
6
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
6.3
6
*
C07AB02
ATC
metoprolol; systemic
2.3
6.3
48
222
UKC02
NOMESCO Finland
Cystoscopy
2.5
6.2
38
158
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
2.8
6.2
31
116
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
6.2
247
1928
J01DB01
ATC
cefalexin; oral
2.0
6.2
358
3109
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.0
6.2
27
94
SFA30
NOMESCO Finland
Three-surface restoration
1.7
6.1
163
1144
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
6.1
137
917
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
6.1
305
2528
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
6.0
81
464
P01AB01
ATC
metronidazole; oral, rectal
1.7
6.0
171
1220
G04CA02
ATC
tamsulosin; oral
2.6
6.0
35
142
WZC30
NOMESCO Finland
Teaching
2.1
6.0
62
323
L17
ICPC
Foot/toe symptom/complaint
1.7
6.0
127
836
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
191
73
46.97
294.21
1.4
1.5
168.18
60.15
e6/l
0.89
156
60
188
72
46.29
289.11
1.4
1.4
8.75
13.26
e6/l
0.19
146
58
85
35
30.16
123.20
1.2
1.1
50.58
39.74
mg/l
0.24
75
28
77
25
37.45
120.50
1.2
1.0
1.11
1.05
u/l
0.27
36
11
81
40
24.82
109.14
1.1
1.1
—
—
—
0
0
81
40
24.82
109.14
1.1
1.1
—
—
—
0
0
76
33
27.87
107.64
1.1
1.0
—
—
—
0
0
77
37
25.23
104.79
1.1
1.1
—
—
—
0
0
64
27
27.76
91.23
1.2
1.2
0.53
0.62
ratio
0.83
43
15
152
358
6.07
65.31
2.4
1.8
380.56
395.48
nmol/l
0.35
144
331
108
233
5.89
49.94
4.7
5.1
-0.33
1.62
mmol/l
3.36
68
198
114
272
5.37
46.91
2.4
2.3
10.26
10.58
g/l
0.46
101
251
37
22
18.34
44.98
1.3
1.2
—
—
—
0
0
260
1208
4.00
42.83
5.8
4.6
36.90
37.42
g/l
0.88
251
1152
280
1368
4.11
42.81
8.0
6.4
1.21
1.21
mmol/l
0.60
248
1200
45
48
10.37
38.68
1.7
3.5
21.23
22.83
mu/l
0.14
45
48
327
1874
4.31
37.49
7.1
4.7
6.24
6.25
mmol/l
0.03
314
1667
248
1195
3.61
36.96
9.5
6.2
1.21
1.21
mmol/l
0.00
239
1116
73
143
5.96
36.86
1.7
1.9
38.93
39.45
u/l
0.07
67
132
101
266
4.68
36.24
1.3
1.2
—
24.08
—
0
19
200
893
3.36
32.71
3.5
2.6
37.58
18.40
ng/l
0.54
100
367
76
175
5.08
31.89
4.7
3.6
4.71
5.04
kpa
2.09
71
168
181
774
3.34
31.57
2.6
1.9
132.66
253.47
u/l
0.78
176
743
122
426
3.62
29.09
3.9
3.6
0.83
0.82
mmol/l
0.72
116
410
65
151
4.91
26.82
4.3
3.7
-0.54
0.82
mmol/l
0.83
30
107
96
304
3.79
26.27
7.1
7.7
107.20
105.12
mmol/l
4.43
96
304
414
3456
11.44
23.76
23.7
10.4
139.93
139.49
mmol/l
5.91
414
3374
265
1589
2.79
22.83
6.1
5.3
8.91
10.40
umol/l
2.10
253
1514
81
257
3.66
21.86
5.8
4.1
—
—
—
0
0
341
2468
2.99
18.22
8.8
6.6
77.08
72.73
u/l
1.09
331
2338
21
5
44.01
17.44
1.1
1.2
—
—
—
0
0
186
1040
2.41
17.00
2.9
2.7
2.32
2.35
mmol/l
2.52
175
973
65
212
3.44
16.63
10.3
12.1
0.10
0.59
mmol/l
0.37
44
167
176
980
2.37
16.03
5.1
2.3
47.85
61.03
u/l
2.15
168
917
102
449
2.68
15.31
1.3
1.3
95.36
153.71
u/ml
0.92
42
187
248
1627
2.27
14.96
3.5
2.5
64.56
71.49
nmol/l
5.27
235
1533
341
2595
2.64
14.18
4.9
3.8
10.37
8.57
mm/h
2.88
321
2455
43
118
3.94
14.12
5.5
4.1
0.67
0.64
%
0.28
43
118
22
14
16.50
14.08
1.1
1.2
—
—
—
0
0
152
833
2.29
13.99
2.2
1.8
0.74
0.88
mg/l
0.49
106
604
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
15
15.40
13.72
1.0
1.2
—
—
—
0
0
202
1253
2.17
13.59
3.6
3.0
24.32
26.88
u/l
1.08
189
1204
380
3080
3.35
13.57
6.2
4.6
14.39
14.31
pmol/l
0.27
368
2878
33
81
4.33
12.55
1.6
2.1
12.30
10.53
mg/l
0.71
33
75
371
3020
2.89
12.09
6.8
4.5
37.36
36.95
mmol/mol
0.41
361
2901
53
187
3.10
11.82
5.0
3.0
1.22
1.22
mmol/l
0.07
48
159
17
9
19.61
11.68
1.4
1.8
—
—
—
0
0
109
564
2.26
11.17
2.1
1.6
403.98
65882766.84
pmol/l
1.29
93
510
21
39
5.61
10.98
1.5
1.4
20.89
22.59
ng/l
0.20
21
39
384
3232
3.09
10.80
5.5
3.5
5.75
5.57
mmol/l
2.17
366
3049
86
408
2.39
10.74
2.0
1.7
—
—
—
0
0
160
973
2.04
10.73
2.7
2.1
3.21
2.48
mg/l
2.41
148
845
90
442
2.32
10.37
3.2
2.3
2.44
2.48
g/l
0.26
80
405
80
381
2.36
9.86
3.3
2.5
22.93
23.68
%
0.22
72
355
78
369
2.37
9.75
2.3
1.5
1257.06
1108.95
nmol/l
0.77
66
295
279
2100
1.97
9.68
9.7
8.5
4.66
3.94
e9/l
5.89
259
1820
94
483
2.22
9.67
3.2
2.3
13.78
14.40
umol/l
0.39
82
444
224
1569
1.91
9.65
4.6
3.1
0.04
0.02
estimate
0.21
67
370
167
1065
1.94
9.53
5.0
3.4
0.00
0.01
estimate
1.08
74
415
102
545
2.15
9.50
3.1
2.3
5759.67
6183.78
u/l
0.06
35
238
122
702
2.04
9.32
2.8
2.5
320.96
309.43
umol/l
0.72
110
644
272
2050
1.92
9.16
5.0
3.3
0.00
6.80
estimate
0.80
78
429
399
3504
3.54
8.96
7.5
5.4
1.74
1.72
mu/l
0.26
391
3361
152
960
1.91
8.79
3.8
3.3
7.64
8.56
mmol/l
1.43
141
844
93
494
2.13
8.74
3.8
3.1
1075.82
768.34
ng/l
0.23
66
386
121
709
1.99
8.71
5.1
4.4
18.63
10.57
mg/mmol
0.42
82
461
191
1303
1.85
8.64
2.4
1.8
98.67
95.22
pmol/l
0.55
127
736
159
1024
1.89
8.62
5.0
2.9
51.74
141.92
e6/l
0.59
129
731
266
2031
1.84
8.15
4.9
3.3
0.00
0.00
estimate
0.50
77
432
12
7
17.60
8.12
1.0
1.0
—
—
—
0
0
132
816
1.90
8.02
2.0
1.5
19.35
20.51
nmol/l
0.37
119
735
383
3336
2.60
7.87
16.3
9.1
94.17
97.09
ml/min/173m2
1.86
366
2938
268
2063
1.82
7.86
5.0
3.3
0.00
0.00
estimate
-0.00
76
412
328
2695
1.97
7.78
4.1
3.0
33.79
32.33
u/l
0.28
313
2610
113
670
1.94
7.75
4.3
2.5
6.95
9.08
e6/l
1.17
106
591
61
289
2.30
7.53
2.2
1.6
—
—
—
0
0
309
2512
1.86
7.28
6.2
4.0
1753.83
623.03
e6/l
—
6
30
16
22
7.51
7.25
1.3
1.5
—
—
—
0
0
35
130
2.85
7.12
16.1
13.2
94.61
94.40
%
0.09
35
130
406
3695
3.61
6.70
21.1
10.9
14.39
19.91
mg/l
7.93
369
2951
383
3387
2.42
6.70
4.9
3.6
1.29
1.49
mmol/l
23.59
371
3252
13
15
8.90
6.60
1.0
1.0
—
—
—
0
0
386
3431
2.47
6.57
5.3
4.0
2.81
2.77
mmol/l
0.39
372
3296
11
10
11.25
6.33
1.2
1.0
—
—
—
0
0
57
286
2.15
6.11
2.3
1.6
—
—
—
0
0
21
63
3.46
6.08
1.8
1.4
—
—
—
0
0
362
3161
2.02
6.07
4.3
3.2
1.42
1.18
mmol/l
8.85
344
3016
11
11
10.23
6.06
1.2
1.1
—
—
—
0
0
17
44
3.98
6.04
1.1
1.1
—
—
nmol/l
—
0
0
16
40
4.12
5.95
1.1
1.1
0.16
0.15
nmol/l
—
9
27
85
503
1.86
5.73
2.6
2.0
2.41
2.41
mmol/l
0.10
77
454
136
924
1.70
5.71
4.3
3.1
1.02
1.02
kg/l
0.06
96
593
12
16
7.68
5.67
1.7
6.9
27.33
241.78
umol/l
—
6
9
10
10
10.21
5.55
1.1
1.3
—
—
—
0
0
10
10
10.21
5.55
1.0
1.0
—
—
—
0
0
10
10
10.21
5.55
1.1
1.2
—
—
—
0
0
10
10
10.21
5.55
1.1
1.1
—
—
—
0
0
131
887
1.69
5.55
4.5
2.7
0.10
0.28
e6/l
3.31
107
607
119
786
1.72
5.52
1.4
1.3
12.25
20.45
iu/ml
1.64
25
209
18
52
3.57
5.51
1.8
2.2
—
—
—
0
0
17
48
3.65
5.38
6.4
2.1
8.39
5.43
pmol/l
0.70
17
48
169
1231
1.62
5.35
4.2
2.7
0.00
0.02
estimate
1.34
68
362
379
3401
2.12
5.33
5.1
3.7
4.54
4.66
mmol/l
1.83
367
3275
8
6
13.55
5.10
1.4
2.3
—
—
—
0
0
17
50
3.50
5.08
1.2
1.3
—
—
—
0
0
33
142
2.44
5.06
1.9
1.8
1.28
1.18
g/l
0.94
33
137
167
1228
1.60
5.00
1.5
1.4
1.88
2.08
u/ml
0.05
50
348
21
72
3.02
4.94
10.2
2.3
1.27
1.04
nmol/l
0.62
21
64
229
1818
1.57
4.89
3.1
2.7
—
—
estimate
—
0
0
54
292
1.97
4.74
3.6
3.9
4.62
4.68
pmol/l
0.17
45
266
79
486
1.77
4.65
4.0
2.7
33.24
384.03
ng/l
2.63
38
242
11
18
6.24
4.63
1.1
1.6
—
—
—
0
0
69
410
1.82
4.55
1.5
1.4
12.57
17.48
iu/l
1.13
64
345
279
2343
1.56
4.45
4.6
3.4
75.84
61.16
ug/l
1.68
267
2237
31
138
2.35
4.43
1.2
1.2
3.75
5.31
—
8
26
48
257
1.98
4.34
3.3
2.6
—
—
—
0
0
48
823
0.53
4.22
1.4
1.6
558.99
983.77
mu/l
7.24
42
695
41
210
2.05
4.18
4.5
2.5
0.15
0.57
e6/l
0.49
41
197
9
13
7.04
4.18
1.0
1.2
—
—
—
0
0
21
80
2.71
4.13
1.3
1.2
46.52
14.71
iu/ml
—
9
21
18
64
2.89
4.00
1.0
1.2
—
—
—
0
0
25
106
2.44
3.98
1.1
1.3
—
—
—
0
0
33
161
2.14
3.83
1.3
1.3
—
—
—
0
0
20
447
0.42
3.71
1.5
1.5
1.15
1.15
ratio
0.00
12
276
20
79
2.61
3.68
1.7
1.4
273.27
342.03
ug/g
0.60
11
41
9
16
5.72
3.67
1.3
2.7
379.89
449.88
u/ml
—
9
16
29
137
2.20
3.64
1.7
1.4
—
—
—
0
0
54
319
1.79
3.63
1.4
1.3
603.27
220.69
u/ml
0.41
49
299
12
30
4.09
3.62
1.3
1.4
—
—
—
0
0
19
74
2.64
3.60
1.5
1.3
—
—
—
0
0
17
63
2.77
3.53
1.2
1.5
—
—
—
0
0
38
202
1.97
3.52
2.3
2.2
62.36
79.80
ml/min/173m2
1.19
14
79
21
447
0.44
3.45
1.4
1.5
0.79
1.20
ratio
1.85
13
276
21
447
0.44
3.45
1.4
1.5
1.25
0.95
ratio
0.74
13
276
20
82
2.51
3.43
1.2
1.2
1.91
7.42
u/ml
1.06
11
33
12
32
3.83
3.41
1.1
1.1
1495.75
1331.75
miu/ml
0.18
12
32
21
441
0.45
3.33
1.4
1.4
—
—
—
0
0
17
66
2.64
3.25
1.2
1.3
—
—
—
0
0
35
187
1.95
3.21
1.2
1.7
—
—
—
0
0
5
5
10.10
2.98
1.0
1.4
—
—
—
0
0
51
316
1.70
2.93
4.2
3.2
28.20
31.85
%
2.53
41
240
7
13
5.46
2.88
1.6
2.1
2.19
1.88
ug/l
—
7
13
102
748
1.48
2.86
1.3
1.3
1.20
7.87
u/ml
4.19
29
293
34
189
1.87
2.80
2.6
2.1
9.07
4.97
iu/ml
—
8
36
12
39
3.14
2.79
1.2
1.3
—
—
—
0
0
12
39
3.14
2.79
1.2
1.3
—
—
—
0
0
12
39
3.14
2.79
1.2
1.3
—
—
—
0
0
167
1347
1.40
2.78
2.2
1.8
1.47
1.30
mmol/l
1.95
148
1212
5
6
8.41
2.75
1.0
1.2
—
—
—
0
0
6
10
6.07
2.70
1.2
1.0
8.83
33.17
u/l
—
6
10
6
10
6.07
2.70
1.2
1.0
71.00
76.21
u/l
—
6
10
17
73
2.38
2.68
1.0
1.1
—
—
—
0
0
15
62
2.47
2.57
1.3
1.3
—
—
—
0
0
119
916
1.42
2.56
2.4
2.0
—
—
—
0
0
5
7
7.21
2.55
1.0
1.1
—
—
—
0
0
5
7
7.21
2.55
1.0
1.1
—
—
—
0
0
6
11
5.51
2.55
1.0
1.2
—
—
—
0
0
11
37
3.02
2.50
1.4
1.3
—
—
—
0
0
11
37
3.02
2.50
1.2
1.3
—
—
—
0
0
11
38
2.94
2.43
1.2
1.3
—
—
—
0
0
11
38
2.94
2.43
1.2
1.3
—
—
—
0
0
5
8
6.31
2.38
1.0
1.1
—
—
—
0
0
5
8
6.31
2.38
1.0
1.3
—
—
—
0
0
5
8
6.31
2.38
1.0
1.1
—
—
—
0
0
9
28
3.26
2.32
1.4
1.4
—
—
—
0
0
36
217
1.72
2.31
1.4
1.5
0.45
0.27
mg/l
0.48
16
84
6
13
4.66
2.28
1.5
1.2
102.67
64.23
nmol/24h
—
6
13
38
235
1.68
2.23
1.4
1.4
—
—
—
0
0
13
54
2.45
2.22
1.0
1.2
—
—
—
0
0
8
24
3.38
2.19
1.0
1.0
151.63
125.17
pmol/l
—
8
24
171
1426
1.33
2.19
2.2
1.8
—
—
—
0
0
56
383
1.53
2.19
3.3
2.8
6.25
5.11
umol/l
0.45
46
314
74
538
1.46
2.15
3.1
2.4
0.92
0.74
e6/l
0.30
45
254
10
235
0.41
2.14
1.3
1.2
—
—
—
0
0
78
574
1.44
2.13
2.0
1.8
1.30
1.32
%
0.15
70
526
14
62
2.30
2.10
1.1
1.3
—
—
—
0
0
9
31
2.94
2.08
1.3
14.2
18.19
6.49
mmol/l
—
9
23
19
98
1.98
1.98
1.2
1.0
—
—
—
0
0
8
28
2.89
1.87
2.5
2.6
—
—
—
0
0
29
176
1.70
1.85
1.7
1.7
39.40
5.77
u/ml
—
6
47
43
619
0.66
1.83
1.7
1.7
3.60
3.27
ratio
0.91
29
449
5
12
4.20
1.83
2.2
1.1
8.76
6.57
nmol/l
—
5
12
47
323
1.51
1.81
1.1
1.0
—
—
—
0
0
67
498
1.41
1.74
4.2
2.6
3.00
4.06
e6/l
0.63
37
217
34
219
1.60
1.74
1.6
1.4
—
—
—
0
0
15
75
2.04
1.71
4.3
3.5
15.91
26.75
mg/l
—
10
55
6
19
3.19
1.66
1.3
2.4
14.45
13.24
umol/l
—
6
19
18
99
1.85
1.60
1.3
1.3
—
1.57
—
0
6
7
27
2.62
1.52
1.0
1.0
—
—
—
0
0
9
37
2.46
1.48
1.0
1.4
—
—
—
0
0
14
73
1.95
1.45
1.6
1.3
—
—
—
0
0
6
23
2.63
1.37
1.3
1.2
—
—
—
0
0
20
120
1.70
1.36
1.7
1.4
176.43
200.52
u/ml
0.22
14
77
5
17
2.96
1.36
1.2
1.4
—
—
—
0
0
5
17
2.96
1.36
1.2
1.4
—
—
—
0
0
5
17
2.96
1.36
1.2
1.4
—
—
—
0
0
6
24
2.52
1.31
1.5
3.4
16.17
24.70
u/ml
—
6
24
5
18
2.80
1.29
1.6
1.4
—
—
—
0
0
8
37
2.18
1.22
1.6
1.4
—
—
—
0
0
27
182
1.52
1.19
1.2
1.2
2.84
3.43
u/ml
0.14
13
101
5
20
2.52
1.15
1.2
1.1
—
—
—
0
0
23
151
1.55
1.14
1.1
1.1
1.52
1.38
u/ml
0.06
11
77
18
111
1.65
1.14
1.3
1.2
—
—
—
0
0
18
112
1.63
1.10
1.3
1.2
—
—
—
0
0
8
41
1.97
1.09
1.0
1.1
—
—
—
0
0
12
68
1.79
1.01
1.3
1.2
—
—
—
0
0
12
68
1.79
1.01
3.2
3.0
4.43
1.72
index
—
7
32
9
51
1.78
0.95
1.2
1.3
—
—
—
0
0
9
51
1.78
0.95
1.2
1.3
—
—
—
0
0
38
489
0.76
0.89
1.4
1.6
3.37
3.33
mmol/l
0.09
23
324
8
43
1.88
0.87
1.6
1.5
—
—
—
0
0
21
294
0.70
0.83
1.4
1.6
64.20
56.71
ug/l
0.38
21
294
43
538
0.78
0.82
1.5
1.5
—
—
—
0
0
14
212
0.65
0.82
1.3
1.5
—
—
—
0
0
340
3268
1.21
0.80
4.3
4.1
—
—
—
0
0
16
108
1.50
0.74
1.2
1.1
2.53
9.14
au/ml
—
6
38
7
39
1.81
0.73
1.6
1.3
—
—
—
0
0
31
394
0.77
0.69
1.3
1.7
—
—
—
0
0
5
28
1.79
0.66
1.4
1.1
—
—
—
0
0
5
28
1.79
0.66
1.0
1.0
—
—
—
0
0
15
103
1.47
0.66
1.6
1.8
—
—
—
0
0
26
335
0.76
0.64
1.7
1.7
—
—
—
0
0
13
87
1.51
0.64
1.6
2.3
—
—
—
0
0
22
165
1.35
0.62
2.9
4.4
2.51
7.49
ug/l
1.25
17
125
8
51
1.58
0.60
1.5
1.1
—
—
—
0
0
6
35
1.72
0.58
2.2
1.3
—
—
—
0
0
12
171
0.69
0.56
1.6
1.6
—
—
—
0
0
6
37
1.63
0.55
1.0
1.6
—
—
—
0
0
123
1123
1.13
0.54
1.5
1.6
—
—
—
0
0
7
46
1.53
0.48
3.0
2.7
5.63
89.59
u/ml
—
7
46
20
155
1.30
0.47
1.6
2.3
2.08
4.78
iu/l
—
7
65
7
48
1.47
0.47
1.9
1.3
—
—
—
0
0
16
120
1.35
0.47
1.1
1.1
0.49
0.32
u/ml
—
6
36
7
50
1.41
0.45
1.6
1.9
—
—
—
0
0
37
315
1.19
0.41
1.4
1.3
192.93
268.30
miu/ml
0.40
14
166
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
14
107
1.32
0.37
1.6
1.9
—
—
—
0
0
25
208
1.21
0.36
2.3
2.2
—
—
—
0
0
37
321
1.17
0.35
1.5
1.4
—
—
—
0
0
10
133
0.75
0.34
1.4
1.3
—
—
—
0
0
85
783
1.11
0.33
2.0
2.0
—
—
—
0
0
7
97
0.72
0.31
1.4
1.5
—
—
—
0
0
21
176
1.20
0.29
2.0
2.3
3.99
5.01
umol/l
0.68
14
131
8
108
0.74
0.29
1.5
1.8
8.06
7.70
mmol/l
—
8
103
130
1237
1.07
0.25
2.4
2.2
—
—
—
0
0
23
199
1.16
0.24
1.5
1.7
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
15
126
1.20
0.21
2.4
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
1115.17
—
0
12
6
52
1.16
0.19
1.8
1.6
0.55
0.50
e9/l
—
6
52
100
955
1.06
0.18
2.2
2.2
—
—
—
0
0
5
66
0.75
0.17
2.2
3.7
31.20
943.11
u/ml
—
5
59
6
78
0.77
0.15
1.2
1.7
—
—
—
0
0
6
78
0.77
0.15
12.8
1.8
12.97
13.07
%
—
6
78
9
81
1.11
0.15
1.4
1.2
—
—
—
0
0
23
209
1.11
0.13
1.0
1.1
0.87
0.83
g/l
0.38
23
209
21
230
0.91
0.12
1.4
1.6
—
—
—
0
0
5
44
1.14
0.10
1.4
1.2
—
—
—
0
0
5
44
1.14
0.10
1.4
1.2
—
—
—
0
0
5
44
1.14
0.10
1.4
1.2
—
—
—
0
0
5
45
1.11
0.10
1.4
1.2
—
—
—
0
0
5
45
1.11
0.10
1.4
1.2
—
—
—
0
0
22
204
1.08
0.09
1.0
1.1
1.46
1.55
g/l
1.12
22
204
6
58
1.03
0.08
1.2
1.9
0.00
0.00
g/l
—
6
52
6
71
0.84
0.07
1.5
1.6
6.88
7.37
mmol/l
—
6
71
19
178
1.07
0.06
2.1
2.6
0.57
0.72
ug/l
—
10
101
23
229
1.00
0.00
3.2
4.2
21.70
22.55
%
—
7
97
135
1349
1.00
0.00
2.5
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.8
—
10.64
—
0
5
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
8.00
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.5
—
53.18
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
5.17
—
0
5
5
53
0.94
-0.00
1.8
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
8.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
-0.00
1.6
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_BENINTRAHYP and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have G6_BENINTRAHYP.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: G6_BENINTRAHYP – Benign intracranial hypertension
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data